A study concluded that serum SOD1 concentration was a better predictor than serum SOD2 concentration, however both SOD1 and SOD2 concentrations have been demonstrated to positively impact the risk of all-cause mortality in patients with lung cancer [130]. This evidence concerns the gene SOD1 and lung carcinoma.